Efekti tronedeljnog tretmana erektalne disfunkcije ekstrakorporalnim udarnim talasima niskog inteziteta
Metadata
Show full item recordAbstract
Although phosphodiesterase 5 (PDE 5) inhibitors represent the gold
standard for medical treatment of erectile dysfunction (ED), they are not
curative. Over recent years, low-intensity extracorporealshock wave therapy
(LI-ESWT) has been proposed as a valid non-invasive therapy approach for
erectile dysfunction. The aim of our work is to assess the shortened, threeweek
low-intensity extracorporeal shock wave treatment of vasculogenic
erectile dysfunction.
The study involved a total of 32 patients with an International Index of
Erectile Function (IIEF) score between 5 and 20, and whose vasculogenic
ED had been proven through Doppler ultrasound. All patients had a washout
period of 1 month after previous therapy and agreed to discontinue the
PDE5-I tgerapy during the follow-ap. The patients were evaluated at
baseline, after 1, 3 and 6 months, with the IIEF, Doppler ultrasound and
Beck Depression Inventory (BDI).
All investigated parameters ( International Index of Erectile Fu...nction, Beck
Depression Inventory and penile Doppler ultrasound parameters) showed
statistically significant improvement just one month after the treatment,
compared to pre-treatment values, in all investigated domains. The
international index of erectile function passed from baseline values of 12.75
± 4.62 to 14.87 ± 5.04 at one month after treatment (p<0.01). This trend
remained positive in IIEF and all the parameters tested at the 3-month and
6-month follow-up.
The shortened three-week low-intensity shock wave treatment of
vasculogenic erectile dysfunction proved to be clinically effective.